New Ask Claude or ChatGPT about any stock, using Bullpen. Bullpen in Claude or ChatGPT. 7 days free
Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Thursday, November 12, 2026

Back to the front page

Looking Back at Another Successful Thesis

DoubleU Games raised its all-cash tender offer for DoubleDown Interactive minority holders to $16.25 per ADS from $11.25 after net cash made the earlier bid untenable.

DDI $781M
The Value Road 4 clicks

From X

@majgeoinvesting 2 clicks

Maj Soueidan on X

The stock’s I’m most interested in from the last group of Delta Sheets: $XBP Post-merger integration story that went bad, quickly. Can the turnaround strategy outlast the high debt burden? New contract wins, potential asset sales and expense cuts give it a glimmer of a hope. It’s high risk, but the re-rate would be pretty significant. Agentic AI. 🤢⏳ $SGRP Has had several failed turnaround attempts of its labor-heavy merchandising model. However, governance improvements + $TRAK becoming a 30% shareholder are interesting. 🤢⏳ $FSI Near-term earnings are being depressed by upfront costs to scale new food-grade contracts and new facility, setting up a potential revenue/margin inflection as those investments begin producing sales. Bad Q2 might have been the “kitchen sink” quarter. 🤔🔥 $ELWT Very interesting business (smart buildings integration). Executive Chairman has done it before. But do they have the access to non-dilutive capital to monetize a large backlog? Should they have waited a year before going public? ⏳ $IRIX Glaucoma consumables are finally showing growth (consumables volume +35%), but system (hardware) placements are not setting the world on fire. Also, other parts of the business are offsetting progress. New CEO has made some real strides. 🤢⏳ $LYTS Profitable industrial compounder driven by accelerating organic growth, good acquisition history and expanding margins. However, they hit their first blip with their last acquisition - Integration issues and weaker margins than expected on the backlog of the acquired business. Might be an interesting buy the pullback set-up to watch. Will probably take a few quarters to know if it’s a short-term issue or something bigger. 🤔🔥 $BOSC Profitable aerospace/defense supply-chain play. Q2 numbers were good, but was more of Q1 delayed orders hitting Q2. Where’s your acquisition! 🤷🔥 $TGEN Despite all the pessimism, I’m still betting on the data center cooling contract win catalyst to come through. Two years ago, hyper-scalers weren’t part of the growth plan, nor was the non-data center power business. Now, they are. ⏳ $FTLF Can the company grow acquisitions, post acquisition? Time will tell… Regardless, they are generating a good deal of earnings and paying down debt deployed as part of the acquisition strategy. 🤔 $CNVS Don’t love ad-tech businesses, but their new all in one solution that has recurring revenue is interesting for now. It supplements their legacy lumpy movie creations business, which they should sell, and their content streaming business. 🤔 $SNT Profitable physical-security technology company with recurring software/service potential and exposure to increasing demand for perimeter protection of critical infrastructure. Can their acquired LiDAR business more than offset their non-dependable legacy business? Stock is falling apart, due to years of lack of execution. 🤔 $IFA.TO Performance-apparel technology company where the opportunity is continued adoption/licensing of its new textile technologies translating into high-margin growth. 🔥 $COV.V Is the long-awaited growth inflection finally happening: Q3 revenue +20%, gross margin hit 67%, EBITDA tripled to $3M, contamination-protection sales +68%, and it has $19M cash with no bank debt. The next couple quarters will tell us a lot. 🤔 🔥 $OML.V Profitable aerospace/defense precision-components company hitting record revenue and backlog, with 1.34x book-to-bill and no debt. Some nice operating-leverage. 🔥

Investor Letters

All letters

Qure Anniversary Update

UniQure’s Huntington’s disease BLA has a May 1, 2027 priority-review date, with an FDA advisory committee expected in late first quarter.

QURE $1.7B
Triple S Special Situations Investing 2 clicks

Big Short: Fidelity & Guaranty

F&G’s main insurer held $66.5 billion of assets against $1.38 billion of statutory capital, while private credit, reinsurance dependence…

FG $3B
Mispriced Assets 5 clicks

Top Rebound Stocks for Nov’26

Texas Pacific Land's 50% selloff reflects faded data-center expectations, while its Permian royalty business generated $498 million of 2025…

TPL $20B
Rebound Capital 5 clicks

Peloton: Beyond The Bike

Peloton’s connected-fitness subscribers fell 9% year over year to 2.475 million, with another high-single-digit holiday decline forecast as…

PTON $2.5B
TSOH Investment Research 4 clicks
MONOY · long

Monotaro CO LTD

MonotaRO, traded as MONOY in the U.S. and 3064 in Japan, is a Japanese MRO distributor recommended as a long.

MONOY $7.3B
Value Investors Club 1 click

Quick note on LSAK and GRPN

Lesaka expects its Bank Zero acquisition to close by end-January 2027, though it could still close this calendar year.

GRPN $499M
Mispriced Assets 5 clicks

DoorDash’s FBA Moment

DoorDash’s $17 billion Instacart deal targets DashMart warehouse scale, where 99%+ order accuracy and faster delivery address the limits of…

DASH $75BKR $42B
MBI Deep Dives 3 clicks

Publications we follow

Every publication on this site, hand-picked.

130 publications

Newsletters 110

YouTube 4

Blogs 15

Seeking Alpha 88 of 294

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

91 accounts
Nominate an account

Investor letters we follow

376 firms

Sectors

Ordered by how often our editor reaches for them.